• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsTechnologySoftware & IT ServicesOptimizeRx
    Picture of OptimizeRx logo

    OPRX — OptimizeRx News Story

    $9.150.000.00%
    us flag iconLast trade - 00:00
    TechnologyAdventurousSmall CapSuper Stock
    • Market Cap
      $172.35m
    • Enterprise Value
      $167.26m
    • Revenue
      $109.43m
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • OPRX Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    OPRX Dividends
    All News

    NASDAQ RESUMED AT 09:56 AM

    Picture of OptimizeRx logoOptimizeRx
    06/03/2026 14:56
    NASDAQ RESUMED  OPRX.O  AT 09:56 AM
    

    Recent news on OptimizeRx

    See all news
    • Brief: Optimizerx Announces Finance Leadership Appointments To Support The Next Phase Of Growth

      12/08/2026 22:20
    • OptimizeRx Corporation reports results for the quarter ended June 30 - Earnings Summary

      12/08/2026 22:01
    • OptimizeRx Q2 revenue beats estimates on operating resilience; reaffirms outlook

      12/08/2026 21:10
    • OptimizeRx Corporation expected to post earnings of 12 cents a share - Earnings Preview

      10/08/2026 21:57
    • Brief: Optimizerx Corp - Enters Credit Agreement With Fifth Third Bank On May 7, 2026 - SEC Filing

      12/05/2026 22:32

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.